NPPA issued a notification regarding fixation of retail price of Rosuvastatin Calcium IP Eq. to Rosuvastatin 20 mg (as film-coated tablet) +Aspirin IP 75 mg (as gastro-resistant tablet) + Clopidogrel Bisulphate IP Eq. to Clopidogrel 75 mg (as film-coated tablet) for M/s Akums Drugs & Pharmaceuticals Ltd. (Manufacturer) & M/s Sun Pharmaceutical Industries Ltd. (Marketer)

Aug 27, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on August 20, 2026, issued a notification regarding fixation of retail price of Rosuvastatin Calcium IP Eq. to Rosuvastatin 20 mg (As film coated tablet) +Aspirin IP 75 mg (As Gastro - resistant Tablet) + Clopidogrel Bisulphate IP Eq. to Clopidogrel 75 mg (as film coated tablet) for M/s Akums Drugs & Pharmaceuticals Ltd. (Manufacturer) & M/s Sun Pharmaceutical Industries Ltd. (Marketer).

The following has been stated: -

•The retail price of each Hard Gelatin Capsule Contains: Rosuvastatin Calcium IP Eq. to Rosuvastatin 20 mg (As film coated tablet) +Aspirin IP 75 mg (As Gastro - resistant Tablet) + Clopidogrel Bisulphate IP Eq. to Clopidogrel 75 mg (as film coated tablet) for M/s Akums Drugs & Pharmaceuticals Ltd. (Manufacturer) & M/s Sun Pharmaceutical Industries Ltd. (Marketer) is 25.21(Rs).

[Notification No.: 19(5303)/2026/DP/NPPA/Div.III/15041/2026]

 


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT